Is Chemo the Key for EGFR Mutation-Positive NSCLC? The Data Too Good to Overlook

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Is Chemo the Key for EGFR Mutation-Positive NSCLC? The Data Too Good to Overlook

By Beacon Medical Interchange FEATURING Jack West

9,993 views

November 2, 2018

Dr. Jack West reviews the remarkable results of the NEJ009 trial that tested the combination ...
read more ↘ of carboplatin/pemetrexed with gefitinib as initial therapy compared to gefitinib followed by chemotherapy in patients with EGFR mutation-positive advanced NSCLC.
↖ read less

Comments 2